AR115411A2 - 8-[3-amino-piperidin-1-il]-xantinas como inhibidores de dpp-iv - Google Patents
8-[3-amino-piperidin-1-il]-xantinas como inhibidores de dpp-ivInfo
- Publication number
- AR115411A2 AR115411A2 ARP190101358A ARP190101358A AR115411A2 AR 115411 A2 AR115411 A2 AR 115411A2 AR P190101358 A ARP190101358 A AR P190101358A AR P190101358 A ARP190101358 A AR P190101358A AR 115411 A2 AR115411 A2 AR 115411A2
- Authority
- AR
- Argentina
- Prior art keywords
- methyl
- dpp
- piperidin
- amino
- xanthines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
8-[3-amino-piperidin-1-il]-xantinas sustituidas como inhibidoras de DPP-IV utilizadas en el tratamiento de la diabetes mellitus de tipo I o tipo II. Reivindicación 1: Un compuesto caracterizado por la fórmula general (1), en donde R se selecciona del grupo que consiste en (3-ciano-piridin-2-il)metilo, (3-ciano-quinolin-2-il)metilo, (4,6-dimetil-pirimidin-2-il)metilo y (4-metil-pirimidin-2-il)metilo, 2-cianobencilo.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004008112A DE102004008112A1 (de) | 2004-02-18 | 2004-02-18 | 8-[3-Amino-piperidin-1-yl]-xanthine, deren Herstellung und Verwendung als Arzneimittel |
Publications (1)
Publication Number | Publication Date |
---|---|
AR115411A2 true AR115411A2 (es) | 2021-01-13 |
Family
ID=34813493
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP190101358A AR115411A2 (es) | 2004-02-18 | 2019-05-22 | 8-[3-amino-piperidin-1-il]-xantinas como inhibidores de dpp-iv |
Country Status (5)
Country | Link |
---|---|
CN (1) | CN1980930B (es) |
AR (1) | AR115411A2 (es) |
DE (1) | DE102004008112A1 (es) |
UA (1) | UA87835C2 (es) |
ZA (1) | ZA200604281B (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20090938A1 (es) * | 2007-08-16 | 2009-08-08 | Boehringer Ingelheim Int | Composicion farmaceutica que comprende un derivado de benceno sustituido con glucopiranosilo |
DE102008010661A1 (de) * | 2008-02-22 | 2009-09-03 | Dr. Felix Jäger und Dr. Stefan Drinkuth Laborgemeinschaft OHG | Verfahren zur Herstellung von Pyridin-2-Boronsäure und Derivaten davon |
CN102311448B (zh) * | 2010-07-07 | 2014-02-19 | 中国科学院广州生物医药与健康研究院 | 噻吩并嘧啶酮类dpp-iv抑制剂 |
WO2013010964A1 (en) * | 2011-07-15 | 2013-01-24 | Boehringer Ingelheim International Gmbh | Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions |
CN103450201B (zh) * | 2012-05-30 | 2017-04-12 | 博瑞生物医药(苏州)股份有限公司 | 手性8‑(3‑氨基哌啶‑1‑基)‑黄嘌呤的制备方法 |
CN103709163B (zh) * | 2012-09-29 | 2016-12-21 | 齐鲁制药有限公司 | 黄嘌呤衍生物、其制备方法及用途 |
CN103319483B (zh) * | 2012-10-19 | 2016-08-03 | 药源药物化学(上海)有限公司 | 一种利拉列汀重要中间体的制备方法 |
CN103936740B (zh) * | 2013-01-23 | 2016-06-29 | 成都苑东生物制药股份有限公司 | 黄嘌呤衍生物 |
CN106188058B (zh) * | 2015-05-29 | 2020-11-06 | 江苏天士力帝益药业有限公司 | 黄嘌呤衍生物 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1953162B9 (de) * | 2001-02-24 | 2012-10-31 | Boehringer Ingelheim Pharma GmbH & Co. KG | Xanthinderivate, deren Herstellung und deren Verwendung als Arzneimittel |
-
2004
- 2004-02-18 DE DE102004008112A patent/DE102004008112A1/de not_active Withdrawn
-
2005
- 2005-02-12 UA UAA200609881A patent/UA87835C2/ru unknown
- 2005-02-12 CN CN2005800054231A patent/CN1980930B/zh active Active
-
2006
- 2006-05-26 ZA ZA200604281A patent/ZA200604281B/en unknown
-
2019
- 2019-05-22 AR ARP190101358A patent/AR115411A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
CN1980930A (zh) | 2007-06-13 |
ZA200604281B (en) | 2007-10-31 |
CN1980930B (zh) | 2012-11-21 |
DE102004008112A1 (de) | 2005-09-01 |
UA87835C2 (en) | 2009-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR115411A2 (es) | 8-[3-amino-piperidin-1-il]-xantinas como inhibidores de dpp-iv | |
EA201100969A1 (ru) | Солевые формы органического соединения | |
TNSN05320A1 (en) | Pyrido` 2, 1-a - isoquinoline derivatives as dpp-iv inhibitors | |
UY29177A1 (es) | Derivados sustituidos de purina, purinona y deazapurina, composiciones que los contienen métodos para su preparación y sus usos | |
MY144322A (en) | 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions | |
TW200606151A (en) | Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions | |
PE20060316A1 (es) | Derivados de prolina como inhibidores de dipeptidil peptidasa-iv | |
AR057705A1 (es) | 3-acilaminobenzanilidas insecticidas | |
PE20110235A1 (es) | Combinaciones farmaceuticas que comprenden linagliptina y metmorfina | |
CO5700767A2 (es) | Procedimiento de tratamiento de rechazo de transplantes | |
UY27946A1 (es) | 8-(3-amino-piperidin-1 il)- xantinas, su preparación y su utilización como medicamentos | |
TW200631580A (en) | Substituted benzoquinolizine derivatives | |
PE20040450A1 (es) | Heteroariloxi-aril-espiro-pirimidina-2,4,6-triona n-sustituida como inhibidores de metaloproteinasa | |
MY142018A (en) | Thiophene derivatives as chk 1 inihibitors | |
NO20090029L (no) | Pyrrolopyrimidiner for farmasoytiske formuleringer | |
TW200603799A (en) | Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions | |
SV1999000047A (es) | Nuevas dihidropirimidinas fef. lea 32792-sv | |
PE20061354A1 (es) | Compuestos 2-amino-4-oxobutil como inhibidores de la dipeptidil peptidas-iv | |
GB0412769D0 (en) | Organic compounds | |
ECSP078062A (es) | Heterociclos de 1,4-dihidropiridina-condensados, procesos para preparar los mismos, uso y composiciones que los contienen | |
UY29885A1 (es) | 2-acilaminotiazol-4-carboxamidas insecticidas | |
ATE507854T1 (de) | Zellselektive implantatoberfläche mit gesteuerter freisetzung bioaktiver wirkstoffe | |
CL2007001748A1 (es) | Compuesto derivado de 2-arilamino-4-aminopirimidinas, inhibidores de la proteina quinasa c-alfa; composiciones farmaceuticas que los contienen; y su uso para tratar o prevenir la diabetes, el cancer, enfermedades cardiovasculares y otras. | |
AR029214A1 (es) | Compuestos inhibidores de fosfodiesterasa - 4: 8 - arilquinolinas sustituidas, composiciones farmaceuticas, metodo de tratamiento que las utiliza | |
CL2004000979A1 (es) | Nonapeptidos acilados tipo lysobacitina, composicion que los contiene metodo de preparacion, util como bactericida. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |